Expression of IL-1β, IL-6 and TNF-α in rats with thioacetamide-induced acute liver failure and encephalopathy: correlation with brain edema

1. Aggarwal S, Kramer D, Yonas H, Obrist W, Kang Y, Martin M, et al. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study. Hepatology. 1994; 19:80-7.10.1002/hep.1840190114Open DOISearch in Google Scholar

2. Hazell AS, Butterworth RF. Hepatic encephalopathy: An update of pathophysiologic mechanisms. Proc Soc Exp Biol Med. 1999; 222:99-112.10.1046/j.1525-1373.1999.d01-120.xSearch in Google Scholar

3. Lewis M, Howdle PD. The neurology of liver failure. QJM. 2003; 96:623-33.10.1093/qjmed/hcg110Search in Google Scholar

4. Shawcross D, Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci. 2005; 62:2295-304.10.1007/s00018-005-5089-0Open DOISearch in Google Scholar

5. Cooper AJ, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev. 1987; 67:440-519.10.1152/physrev.1987.67.2.440Search in Google Scholar

6. Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003; 125:755-64.10.1016/S0016-5085(03)01051-5Search in Google Scholar

7. Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol. 2004; 40: 247-54.10.1016/j.jhep.2003.10.01614739095Open DOISearch in Google Scholar

8. Rolando N, Wade J, Davalos M, Wendon J, Philpott- Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000; 32:734-9.10.1053/jhep.2000.1768711003617Open DOISearch in Google Scholar

9. Chu CJ, Wang SS, Lee FY, Chang FY, Lin HC, Hou MC, et al. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamideinduced fulminant hepatic failure. Eur J Clin Invest. 2001; 31:156-63.10.1046/j.1365-2362.2001.00775.x11168455Open DOISearch in Google Scholar

10. Zimmermann C, Ferenci P, Pifl C, Yurdaydin C, Ebner J, Lassmann H, et al. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology. 1989; 9:594-601.10.1002/hep.18400904142564368Open DOISearch in Google Scholar

11. Reddy PV, Murthy C, Reddanna P. Fulminant hepatic failure induced oxidative stress in nonsynaptic mitochondria of cerebral cortex in rats. Neurosci Lett. 2004; 368:15-20.10.1016/j.neulet.2004.06.046Search in Google Scholar

12. Swapna I, Kumar KV, Reddy PV, Murthy C, Reddanna P, Senthilkumaran B. Phospholipid and cholesterol alterations accompany structural disarray in myelin membrane of rats with hepatic encephalopathy induced by thioacetamide. Neurochem Int. 2006; 49:238-44.10.1016/j.neuint.2006.01.012Search in Google Scholar

13. Norton NS, McConnell JR, Rodriguez-Sierra JF. Behavioral and physiological sex differences observed in an animal model of fulminant hepatic encephalopathy in the rat. Physiol Behav. 1997; 62:1113-24.10.1016/S0031-9384(97)00267-9Open DOISearch in Google Scholar

14. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature. 2001; 413:527-31.10.1038/35097089Search in Google Scholar

15. Fride E, Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur J Pharmacol. 1993; 231:313-4.10.1016/0014-2999(93)90468-WSearch in Google Scholar

16. Zhan C, Yang J. Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacol Res. 2006; 53:303-9.10.1016/j.phrs.2005.12.00816459097Search in Google Scholar

17. Schnur J, Olah J, Szepesi A, Nagy P, Thorgeirsson SS. Thioacetamide-induced hepatic fibrosis in transforming growth factor beta-1 transgenic mice. Eur J Gastroenterol Hepatol. 2004; 16:127-33.10.1097/00042737-200402000-0000215075984Open DOISearch in Google Scholar

18. Honda H, Ikejima K, Hirose M, Yoshikawa M, Lang T, Enomoto N, et al. Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology. 2002; 36:12-21.10.1053/jhep.2002.3368412085344Open DOISearch in Google Scholar

19. Chu CJ, Chen CT, Wang SS, Lee FY, Chang FY, Lin HC, et al. Hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of endotoxin and tumor necrosis factor-alpha. Zhonghua Yi Xue Za Zhi (Taipei). 2001; 64:321-30.Search in Google Scholar

20. Kato M, Hughes RD, Keays RT, Williams R. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology. 1992; 15:1060-6.10.1002/hep.18401506151592344Open DOISearch in Google Scholar

21. Maness LM, Kastin AJ, Farrell CL, Banks WA. Fate of leptin after intracerebroventricular injection into the mouse brain. Endocrinology. 1998; 139:4556-62.10.1210/endo.139.11.63199794465Search in Google Scholar